CVS: Copycat drugs may bring price cuts of 40-50% By: CNBC.com News March 12, 2015 at 07:14 AM EDT Copycat biotech drugs in the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, said a top CVS Health exec. Read More >> Related Stocks: AbbVie Amgen Biogen Idec CVS Health Corp Express Scripts Holding Gilead Sciences Hospira Johnson & Johnson Merck & Co Mylan Novartis Ag ADR Pfizer Teva Pharmaceutical Industries ADR